SALT
LAKE CITY, April 24, 2024 /PRNewswire/ --
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or
"Co-Dx"), a molecular diagnostics company with a unique, patented
platform for the development of molecular diagnostic tests,
announced today that the Company will be hosting a booth and
delivering a presentation at the 9th Asia Pacific Region
Conference (APRC) of the International Union Against Tuberculosis
and Lung Disease on April 26-29, 2024
in Taipei, Taiwan.
The theme for the 2024 conference is "Shaping a Safer World
Through High-Quality Holistic Healthcare," reflecting the
organizers' vision to discuss current evidence, share ideas and
information, and accelerate innovation. Attendees are anticipated
to include the world's leaders in the fields of tuberculosis,
emerging respiratory infectious disease, universal health coverage,
and the effects of environmental factors on communicable diseases
(especially tuberculosis) and non-communicable diseases.
Joseph Featherstone, the
Company's Executive VP of Business Development, will be delivering
a presentation on April
27th on accessible TB diagnostics on the Co-Dx
PCR Pro™.
To learn more about the event, including registration details,
please visit here. Attendees interested in learning more about
Co-Dx and its products, including its upcoming Co-Dx PCR Pro
instrument and tests, are invited to visit the Company at Booth
B20.
*The Co-Dx PCR platform (including the PCR Home™, PCR Pro™,
mobile app, and all associated tests) is subject to review by the
FDA and/or other regulatory bodies and is not yet available for
sale. The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are
currently under review by the FDA.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures and markets
state-of-the-art diagnostics technologies. The Company's
technologies are utilized for tests that are designed using the
detection and/or analysis of nucleic acid molecules (DNA or RNA).
The Company also uses its proprietary technology to design specific
tests for its Co-Dx PCR at-home and point-of-care platform and to
locate genetic markers for use in applications other than
infectious disease.Co-Diagnostics.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-and-deliver-presentation-at-aprc-2024-in-taiwan-302125790.html
SOURCE Co-Diagnostics